Abstract
Metabolic Engineering (ME) provides the know-how for the reconstruction of microorganisms, in order to provide higher production rates of biotechnological products and increase their potential application in several industries, particularly those pharmaceutical, food and environmental. However, microbial metabolic cell reconstruction has limitations. Metabolic Control Analysis (MCA) allows the evaluation of the reliability of the changes performed by ME, emphasizing the importance of the whole pathways rather than individual pathway reactions resulting from simple flux analysis. This led to an increased emphasis on the regulatory structure of the network. The use of MCA becomes indispensable to quantify metabolic parameters, particularly those related with direct genetic modifications. However, this type of analysis is not a common practice. In the present study MCA is exemplified as a tool of ME, being demonstrated its practical application in drug delivery and in the production of three relevant biotechnological products (penicillin V, llysine and glycerol).
Keywords: Control coefficient, drug delivery, enzyme, glycerol, kinetics, l-lysine, metabolic control analysis, penicillin V.
Current Bioinformatics
Title:Metabolic Control Analysis and its Applications
Volume: 9 Issue: 5
Author(s): Ana Meireles and Manuel Simoes
Affiliation:
Keywords: Control coefficient, drug delivery, enzyme, glycerol, kinetics, l-lysine, metabolic control analysis, penicillin V.
Abstract: Metabolic Engineering (ME) provides the know-how for the reconstruction of microorganisms, in order to provide higher production rates of biotechnological products and increase their potential application in several industries, particularly those pharmaceutical, food and environmental. However, microbial metabolic cell reconstruction has limitations. Metabolic Control Analysis (MCA) allows the evaluation of the reliability of the changes performed by ME, emphasizing the importance of the whole pathways rather than individual pathway reactions resulting from simple flux analysis. This led to an increased emphasis on the regulatory structure of the network. The use of MCA becomes indispensable to quantify metabolic parameters, particularly those related with direct genetic modifications. However, this type of analysis is not a common practice. In the present study MCA is exemplified as a tool of ME, being demonstrated its practical application in drug delivery and in the production of three relevant biotechnological products (penicillin V, llysine and glycerol).
Export Options
About this article
Cite this article as:
Meireles Ana and Simoes Manuel, Metabolic Control Analysis and its Applications, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140515230435
DOI https://dx.doi.org/10.2174/1574893609666140515230435 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Androgen Deficiency in Aging Male Questionnaire for the Clinical Detection of Testosterone Deficiency in a Population of Black Sub-Saharan African Men with Type 2 Diabetes Mellitus: Is it a Reliable Tool?
Current Diabetes Reviews CDK Inhibitors: From the Bench to Clinical Trials
Current Drug Targets Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors
Current Medicinal Chemistry The Promising Role of Plant Tannins as Bioactive Antidiabetic Agents
Current Medicinal Chemistry Subject Index To Volume 7
Current Drug Targets Gender Differences in Ischemic Heart Disease
Recent Patents on Cardiovascular Drug Discovery Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
Current Pharmaceutical Design Adrenomedullin: Exciting New Horizons
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Functional Logic of Cytosolic 5’-Nucleotidases.
Current Medicinal Chemistry The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Current Drug Metabolism Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell
Endocrine, Metabolic & Immune Disorders - Drug Targets Fenofibrate and Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Possibilities and Limits of Ovarian Reserve Testing in ART
Current Pharmaceutical Biotechnology The Association between Serum Asymmetric Dimethylarginine and Coronary Atherosclerotic Plaque in an Asymptomatic Population
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) In Silico Bioactivity Prediction of Methoxime-3,4-dephostatin Derivatives on Human PTP1B: Search for Novel Antidiabetic Leads
Letters in Drug Design & Discovery Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
CNS & Neurological Disorders - Drug Targets Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography
Endocrine, Metabolic & Immune Disorders - Drug Targets Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) Cannabinoids and Schizophrenia: Therapeutic Prospects
Current Pharmaceutical Design Antioxidant and Anti-inflammatory Properties of Yttrium Oxide Nanoparticles: New Insights into Alleviating Diabetes
Current Diabetes Reviews